Abstract P2-11-15: A novel scoring system based on the clinical and genomic variables to predict the early relapse in estrogen receptor-positive/HER2-negative (ER+/HER2-) breast cancer

Authors: Caijin Lin, Jiayi Wu, Shuning Ding, Lisa Andriani, Weilin Chen, Deyue Liu, Li Zhu

Published: 2020-03-26

DOI: 10.1158/1538-7445.sabcs19-p2-11-15

Source: Full article